相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Molecular sampling of prostate cancer: a dilemma for predicting disease progression
Andrea Sboner et al.
BMC MEDICAL GENOMICS (2010)
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort
Raquel Esgueva et al.
MODERN PATHOLOGY (2010)
TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis
Kari Rostad et al.
APMIS (2009)
TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
Anuradha Gopalan et al.
CANCER RESEARCH (2009)
TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma
Roula Albadine et al.
MODERN PATHOLOGY (2009)
Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma
Bo Han et al.
MODERN PATHOLOGY (2009)
Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion
Charles C. Guo et al.
MODERN PATHOLOGY (2009)
Androgen Regulated Genes in Human Prostate Xenografts in Mice: Relation to BPH and Prostate Cancer
Harold D. Love et al.
PLOS ONE (2009)
Transition Zone and Anterior Stromal Prostate Cancers: Zone of Origin and Intraprostatic Patterns of Spread at Histopathology
Sebastien Bouye et al.
PROSTATE (2009)
Prognostic significance of prostate cancer originating from the transition zone
Christopher R. King et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Anterior-predominant prostatic tumors: Zone of origin and pathologic outcomes at radical prostatectomy
Hikmat A. Al-Ahmadie et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer
Rohit Mehra et al.
CANCER RESEARCH (2008)
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications
Juan-Miguel Mosquera et al.
CLINICAL CANCER RESEARCH (2008)
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
Maisa Yoshimoto et al.
MODERN PATHOLOGY (2008)
Differential gene expression in the peripheral zone compared to the transition zone of the human prostate gland
E. E. Noel et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2008)
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
G. Attard et al.
ONCOGENE (2008)
Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers
Ashish B. Rajput et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: Molecular evidence for an independent group of diseases
Rohit Mehra et al.
CANCER RESEARCH (2007)
Gene fusions between TMPRSS2 and ETS family genes in prostate cancer:: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues
Jiangling J. Tu et al.
MODERN PATHOLOGY (2007)
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
TMPRSS2-ERG fusion prostate cancer:: An early molecular event associated with invasion
Sven Perner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Morphological features of TMPRSS2-ERG gene fusion prostate cancer
J-M Mosquera et al.
JOURNAL OF PATHOLOGY (2007)
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis
Jacques Lapointe et al.
MODERN PATHOLOGY (2007)
Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells
Sangkil Nam et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Gene expression profiling of the human prostate zones
Leonie van der Heul-Nieuwenhuijsen et al.
BJU INTERNATIONAL (2006)
TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions
Nuno Cerveira et al.
NEOPLASIA (2006)
TMPRSS2:: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
Sven Perner et al.
CANCER RESEARCH (2006)
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer
Jianghua Wang et al.
CANCER RESEARCH (2006)
Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement
Maisa Yoshimoto et al.
NEOPLASIA (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
G Petrovics et al.
ONCOGENE (2005)
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer
MA Rubin et al.
CANCER RESEARCH (2004)
Biochemical recurrence following radical prostatectomy: A comparison between prostate cancers located in different anatomical zones
H Augustin et al.
PROSTATE (2003)
Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour
BA Shannon et al.
PATHOLOGY (2003)
Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens
AM Wise et al.
UROLOGY (2002)
Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: Differences between tumours located in the transition zone and in the peripheral zone
A Erbersdobler et al.
EUROPEAN UROLOGY (2002)
Patterns of spread of adenocarcinoma in the prostate as related to cancer volume
JE McNeal et al.
PROSTATE (2001)
An analysis of 148 consecutive transition zone cancers: Clinical and histological characteristics
M Noguchi et al.
JOURNAL OF UROLOGY (2000)